Cargando…

Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the cancer types with poor prognosis. To effectively treat HCC, new molecular targets and therapeutic approaches must be identified. 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/inosine monophosphate (IMP) cyclohydrolase (ATIC),...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Minjing, Jin, Changzhu, Xu, Maolei, Zhou, Ling, Li, Defang, Yin, Yancun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732395/
https://www.ncbi.nlm.nih.gov/pubmed/29246230
http://dx.doi.org/10.1186/s12964-017-0208-8
_version_ 1783286687071207424
author Li, Minjing
Jin, Changzhu
Xu, Maolei
Zhou, Ling
Li, Defang
Yin, Yancun
author_facet Li, Minjing
Jin, Changzhu
Xu, Maolei
Zhou, Ling
Li, Defang
Yin, Yancun
author_sort Li, Minjing
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) is one of the cancer types with poor prognosis. To effectively treat HCC, new molecular targets and therapeutic approaches must be identified. 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/inosine monophosphate (IMP) cyclohydrolase (ATIC), a bifunctional protein enzyme, catalyzes the last two steps of the de novo purine biosynthetic pathway. Whether ATIC contributes to cancer development remains unclear. METHODS: ATIC mRNA levels in different types of human HCC samples or normal tissues were determined from Gene Expression across Normal and Tumor tissue (GENT) database. The expression level of ATIC in human HCC samples or cell lines were examined by RT-PCR and western blot. Overall survival and disease-free survival of HCC patients in the ATIC low and ATIC high groups were determined by Kaplan-Meier analysis. Effects of ATIC knockdown by lentivirus infection were evaluated on cell-proliferation, cell-apoptosis, colony formation and migration. The mechanisms involved in HCC cells growth, apoptosis and migration were analyzed by western blot and Compound C (C-C) rescue assays. RESULTS: Here, we first demonstrated that expression of ATIC is aberrantly up-regulated in HCC tissues and high level of ATIC is correlated with poor survival in HCC patients. Knockdown of ATIC expression resulted in a dramatic decrease in proliferation, colony formation and migration of HCC cells. We also identified ATIC as a novel regulator of adenosine monophosphate-activated protein kinase (AMPK) and its downstream signaling mammalian target of rapamycin (mTOR). ATIC suppresses AMPK activation, thus activates mTOR-S6 K1-S6 signaling and supports growth and motility activity of HCC cells. CONCLUSION: Taken together, our results indicate that ATIC acts as an oncogenic gene that promotes survival, proliferation and migration by targeting AMPK-mTOR-S6 K1 signaling. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12964-017-0208-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5732395
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57323952017-12-21 Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling Li, Minjing Jin, Changzhu Xu, Maolei Zhou, Ling Li, Defang Yin, Yancun Cell Commun Signal Research BACKGROUND: Hepatocellular carcinoma (HCC) is one of the cancer types with poor prognosis. To effectively treat HCC, new molecular targets and therapeutic approaches must be identified. 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/inosine monophosphate (IMP) cyclohydrolase (ATIC), a bifunctional protein enzyme, catalyzes the last two steps of the de novo purine biosynthetic pathway. Whether ATIC contributes to cancer development remains unclear. METHODS: ATIC mRNA levels in different types of human HCC samples or normal tissues were determined from Gene Expression across Normal and Tumor tissue (GENT) database. The expression level of ATIC in human HCC samples or cell lines were examined by RT-PCR and western blot. Overall survival and disease-free survival of HCC patients in the ATIC low and ATIC high groups were determined by Kaplan-Meier analysis. Effects of ATIC knockdown by lentivirus infection were evaluated on cell-proliferation, cell-apoptosis, colony formation and migration. The mechanisms involved in HCC cells growth, apoptosis and migration were analyzed by western blot and Compound C (C-C) rescue assays. RESULTS: Here, we first demonstrated that expression of ATIC is aberrantly up-regulated in HCC tissues and high level of ATIC is correlated with poor survival in HCC patients. Knockdown of ATIC expression resulted in a dramatic decrease in proliferation, colony formation and migration of HCC cells. We also identified ATIC as a novel regulator of adenosine monophosphate-activated protein kinase (AMPK) and its downstream signaling mammalian target of rapamycin (mTOR). ATIC suppresses AMPK activation, thus activates mTOR-S6 K1-S6 signaling and supports growth and motility activity of HCC cells. CONCLUSION: Taken together, our results indicate that ATIC acts as an oncogenic gene that promotes survival, proliferation and migration by targeting AMPK-mTOR-S6 K1 signaling. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12964-017-0208-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-12-16 /pmc/articles/PMC5732395/ /pubmed/29246230 http://dx.doi.org/10.1186/s12964-017-0208-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Li, Minjing
Jin, Changzhu
Xu, Maolei
Zhou, Ling
Li, Defang
Yin, Yancun
Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling
title Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling
title_full Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling
title_fullStr Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling
title_full_unstemmed Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling
title_short Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling
title_sort bifunctional enzyme atic promotes propagation of hepatocellular carcinoma by regulating ampk-mtor-s6 k1 signaling
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732395/
https://www.ncbi.nlm.nih.gov/pubmed/29246230
http://dx.doi.org/10.1186/s12964-017-0208-8
work_keys_str_mv AT liminjing bifunctionalenzymeaticpromotespropagationofhepatocellularcarcinomabyregulatingampkmtors6k1signaling
AT jinchangzhu bifunctionalenzymeaticpromotespropagationofhepatocellularcarcinomabyregulatingampkmtors6k1signaling
AT xumaolei bifunctionalenzymeaticpromotespropagationofhepatocellularcarcinomabyregulatingampkmtors6k1signaling
AT zhouling bifunctionalenzymeaticpromotespropagationofhepatocellularcarcinomabyregulatingampkmtors6k1signaling
AT lidefang bifunctionalenzymeaticpromotespropagationofhepatocellularcarcinomabyregulatingampkmtors6k1signaling
AT yinyancun bifunctionalenzymeaticpromotespropagationofhepatocellularcarcinomabyregulatingampkmtors6k1signaling